Marc Carrier/X
Aug 18, 2025, 23:53
Radiotherapy and VTE Risk: Insights from Marc Carrier and Colleagues
Marc Carrier, Professor at Ottawa Hospital Research Institute, recently has shared a post on X:
“Radiotherapy is essential in cancer care, but evidence shows it may independently raise the risk of VTE.
This review in RPTH journal highlights mechanisms, diagnostic challenges, and why tailored thromboprophylaxis, not blanket use, is needed.”
Read the full article here.
Title: Radiotherapy—the not-so-insignificant contributor to cancer-associated venous thrombosis
Authors: Gerard Gurumurthy, Jacob Miller, Marc Carrier, Alok Khorana, Jecko Thachil
Stay informed on all science in Hematology with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies